[go: up one dir, main page]

SE8106656L - Nya hydroxifenyltetrahydropyridinderivat, salter derav, forfarande och mellanprodukter vid forfarandet, anvendning som lekemedel och kompositioner innehallande dem - Google Patents

Nya hydroxifenyltetrahydropyridinderivat, salter derav, forfarande och mellanprodukter vid forfarandet, anvendning som lekemedel och kompositioner innehallande dem

Info

Publication number
SE8106656L
SE8106656L SE8106656A SE8106656A SE8106656L SE 8106656 L SE8106656 L SE 8106656L SE 8106656 A SE8106656 A SE 8106656A SE 8106656 A SE8106656 A SE 8106656A SE 8106656 L SE8106656 L SE 8106656L
Authority
SE
Sweden
Prior art keywords
hydrogen
carbon atoms
salts
hydroxifenyltetrahydropyridine
intermediates
Prior art date
Application number
SE8106656A
Other languages
English (en)
Other versions
SE450252B (sv
Inventor
L Nedelec
J Guillaume
C Dumont
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of SE8106656L publication Critical patent/SE8106656L/sv
Publication of SE450252B publication Critical patent/SE450252B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/42—Oxygen atoms attached in position 3 or 5
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
SE8106656A 1980-12-15 1981-11-10 Nya hydroxifenyl- tetrahydropyridinderivat, salter derav, ett framstellningsforfarande och farmaceutiska kompositioner innehallande dem SE450252B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8026540A FR2496099A1 (fr) 1980-12-15 1980-12-15 Nouveaux derives de l'hydroxyphenyl tetrahydropyridine, leurs sels, procede et intermediaires de preparation, application a titre de medicaments et compositions les renfermant

Publications (2)

Publication Number Publication Date
SE8106656L true SE8106656L (sv) 1982-06-16
SE450252B SE450252B (sv) 1987-06-15

Family

ID=9249073

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8106656A SE450252B (sv) 1980-12-15 1981-11-10 Nya hydroxifenyl- tetrahydropyridinderivat, salter derav, ett framstellningsforfarande och farmaceutiska kompositioner innehallande dem

Country Status (13)

Country Link
US (1) US4382942A (sv)
JP (1) JPS57123164A (sv)
AT (1) AT376662B (sv)
BE (1) BE891469A (sv)
CA (1) CA1175437A (sv)
CH (1) CH651022A5 (sv)
DE (1) DE3149703A1 (sv)
ES (1) ES8207141A1 (sv)
FR (1) FR2496099A1 (sv)
GB (1) GB2092132B (sv)
IT (1) IT1172150B (sv)
NL (1) NL8105623A (sv)
SE (1) SE450252B (sv)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0192522B1 (fr) * 1985-02-01 1988-08-31 LABORATOIRE L. LAFON Société anonyme dite: 1-ethyl - 3-hydroxy-3-phénylpipéridine, procédé de préparation et utilisation en thérapeutique
FR2576898B1 (fr) * 1985-02-01 1988-01-08 Lafon Labor Derives de 3-phenyl-tetrahydropyridine, procede de preparation et utilisation en therapeutique
EP0398413A1 (en) * 1989-05-16 1990-11-22 Duphar International Research B.V "3,4-dehydropiperidine derivatives having psychotropic activity
US5296497A (en) * 1989-05-16 1994-03-22 Duphar International Research B.V. 3,4-dehydropiperidine derivatives having psychotropic activity
FR2721513B1 (fr) * 1994-06-23 1996-09-06 Lafon Labor Utilisation de dérivés de 1,2,5,6-tétrahydropyridine pour la fabrication de médicaments à effet sédatif.
FR2721514B1 (fr) * 1994-06-23 1996-09-06 Lafon Labor Compositions thérapeutiques comprenant des 3-phényl-3-hydroxypipéridines.
DE102004036349A1 (de) * 2004-07-27 2006-03-23 Grünenthal GmbH Substituierte 3-Phenylpiperidin-Derivate
WO2024227763A1 (en) * 2023-05-03 2024-11-07 Oncorena Ab Synthesis of orellanine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2498431A (en) * 1945-06-13 1950-02-21 Hoffmann La Roche 2-and 4-homocyclyl substituted piperidines
US3523950A (en) * 1967-12-13 1970-08-11 Robins Co Inc A H Certain 4 - phenyl - 1,2,3,6 - tetrahydropyridyl-n-lower alkylene-ureas and derivatives
FR2310761A1 (fr) * 1975-05-16 1976-12-10 Roussel Uclaf Nouveaux derives de la phenyl-piperidine et leurs sels, procede de preparation et application a titre de medicaments
FR2310762A1 (fr) * 1975-05-16 1976-12-10 Roussel Uclaf Nouveaux derives n-substitues de la phenyl piperidine et leurs sels, procede de preparation et application a titre de medicaments
US4302462A (en) * 1979-12-20 1981-11-24 Sterling Drug Inc. 4(or 3)-(3,4-Dihydroxyphenyl)pyridines, their cardiotonic use and cardiotonic use of their methyl ethers

Also Published As

Publication number Publication date
AT376662B (de) 1984-12-27
US4382942A (en) 1983-05-10
ES507939A0 (es) 1982-09-01
ATA536681A (de) 1984-05-15
IT8149903A1 (it) 1983-06-14
GB2092132B (en) 1985-02-13
CA1175437A (fr) 1984-10-02
DE3149703A1 (de) 1982-06-24
NL8105623A (nl) 1982-07-01
FR2496099B1 (sv) 1983-07-29
JPS57123164A (en) 1982-07-31
GB2092132A (en) 1982-08-11
IT1172150B (it) 1987-06-18
IT8149903A0 (it) 1981-12-14
CH651022A5 (fr) 1985-08-30
SE450252B (sv) 1987-06-15
FR2496099A1 (fr) 1982-06-18
ES8207141A1 (es) 1982-09-01
BE891469A (fr) 1982-06-14

Similar Documents

Publication Publication Date Title
AU529426B2 (en) 4-amino-2-ureido-pyrimidine-5-carboxylic acid anilides and their use in treating lipometabolism disturbances and adiposity
NO820264L (no) Fremgangsmaate for fremstilling av 2-penemforbindelser
ES480605A1 (es) Procedimiento para la obtencion de derivados o-sustituidos del (mas)-cianidanol-3.
ES8400393A1 (es) Un procedimiento para la preparacion de nuevos derivados de ariletanolamina.
AU1178588A (en) New 19-norsteroids substituted at the 7-position, their preparation, their application as drugs and the pharmaceutical compositions containing them
DE3069813D1 (en) Pharmaceutical composition containing a diphenylhydantoin derivative, derivatives used and their preparation
SE8204918L (sv) Nya 3-amino-pregn-5-en-derivat, deras salter, sett for framstellning och anvendning derav som lekemedel och kompositioner innehallande dem
SE8106656L (sv) Nya hydroxifenyltetrahydropyridinderivat, salter derav, forfarande och mellanprodukter vid forfarandet, anvendning som lekemedel och kompositioner innehallande dem
IE43847L (en) N-substituted phenylpiperidine derivatives.
DE3170937D1 (en) 2-(1,4-benzodioxan-2-ylalkyl) imidazoles, their preparation and pharmaceutical compositions containing them
ATE15370T1 (de) 3-piperidinyl-indole derivate, ihre salze, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel und diese enthaltende arzneimittel.
ATE8786T1 (de) Indolobenzoxazinderivate, ihre salze, verfahren zur herstellung, ihre verwendung als arzneimittel und sie enthaltende zusammensetzungen.
ES486049A1 (es) Procedimiento para la obtencion de derivados aminopropanoli-cos de la 6-hidroxi-2,3,4,5-tetrahidro-1h-1-benzazepin-2-ona
ES8200648A2 (es) Procedimiento de preparacion de compuestos opacificantes para radiografia y similares
SE8004129L (sv) Nya tetrahydropyridin-4-yl-indolderivat samt salter derav, framstellning och anvendning derav sasom lekemedel samt kompositioner innehallande dessa foreningar
SE7909367L (sv) Sett att framstella piperidyl-indol-derivat, ny framstelld forening och dess salter samt anvendning derav sasom lekemedel och farmaceutiska kompositioner innehallande dessa foreningar
SE7706201L (sv) Sett att framstella nya fenetylaminderivat och salter derav
KR890701584A (ko) 20, 21-디노르에비나메닌의 신규 치환 유도체, 그의 제조 방법 및 이 방법으로 얻는 신규 중간체, 약제로서의 그의 용도 및 그를 함유하는 제약 조성물
ES544955A0 (es) Procedimiento para preparar derivados monobasicos de disobu-tamida
ATE7498T1 (de) Cycloheptindolderivate und ihre saeureadditionssalze, ihre herstellung, ihre verwendung als arzneimittel und sie enthaltende zusammensetzungen.
DE3874920D1 (de) Benzimidazol-2-one-derivate, deren salze, verfahren und zwischenprodukte zu deren herstellung, deren anwendung als arzneimittel und sie enthaltende zusammensetzungen.
ATE81127T1 (de) 4-morpholinyl 1h-indol-derivate, ihre salze, verfahren und zwischenprodukte zur herstellung, verwendung als arzneimittel, sie enthaltende zusammensetzungen.
GB2012260A (en) 4-desacetoxy-4 alpha -hydroxyindole- dihydroindoles, pharmaceutical formulations containing them and their use as antimitotic agents
DE3168174D1 (en) Cephalosporin derivatives, process for their preparation and pharmaceutical compositions containing them
EP0424248A3 (en) 20,21-dinoreburnamine derivatives, substituted in position 15, process for their preparation and novel intermediates so obtained, their use as medicines and compositions containing them

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8106656-5

Effective date: 19900706

Format of ref document f/p: F